— Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter of 2020, vs. $1.09 per share expected.
— Revenue increased 10% annually to $221.6 million during the three-month period, vs. $226.99 million expected
— US revenue rose 8% to $185.6 million, while overseas revenue moved up 29% to $36 million
— Third-quarter gross margin was 82%, down from 83% reported a year earlier
— Announced initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading Pivotal Randomized Controlled Trial during the quarter
— Expects full-year 2020 revenue to be in the range of $846 million to $877 million, up 10% to 14% respectively
— Confirms full-year 2020 unadjusted operating margin guidance in the range of 28% to 30%
Most Popular
Key highlights from Bank of America’s (BAC) Q4 2024 earnings results
Bank of America Corporation (NYSE: BAC) reported its fourth quarter 2024 earnings results today. Revenue, net of interest expense, was $25.3 billion, up 15% year-over-year. Net income was $6.7 billion,
US Bancorp (USB) Q4 profit rises on higher revenues, beats estimates
U.S. Bancorp (NYSE: USB) Thursday reported an increase in revenue and profit for the fourth quarter of 2024. Earnings also came in above analysts' forecasts. Total net revenue increased 3.7%
UnitedHealth Group (UNH) Q4 2024 Earnings: Key financials and quarterly highlights
UnitedHealth Group (NYSE: UNH) reported its fourth quarter 2024 earnings results today. Total revenues were $100.8 billion compared to $94.4 billion reported in the same period a year ago. Net